| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-17,593 | -16,762 | -13,552 | -13,283 | -10,849 |
|
Exploration Expenses
|
-317 | -255 | -442 | -700 | -3,428 |
|
Research and Development Expenses
|
0 | -- | 0 | 0 | -2,349 |
| Other Income/Expense, Operating
|
0 | -- | 0 | 0 | -128 |
|
Operating Income/Expenses
|
-17,910 | -17,017 | -13,994 | -13,983 | -16,754 |
|
Total Operating Profit/Loss
|
-17,910 | -17,017 | -13,994 | -13,983 | -16,754 |
| Total Net Finance Income/Expense
|
-5,489 | -10,731 | -7,274 | -8,147 | 328 |
| Net Investment Income
|
126,453 | 65,220 | -8,477 | 9,248 | 27,628 |
| Irregular Income/Expenses
|
-173,374 | -170,104 | 0 | -51,884 | 1,338 |
|
Other Income/Expense, Non-Operating
|
-1,916 | -833 | 298 | 100 | 11 |
|
Non-Operating Income/Expenses, Total
|
-54,326 | -116,448 | -15,453 | -50,683 | 29,305 |
|
Pretax Income
|
-72,236 | -133,465 | -29,447 | -64,666 | 12,551 |
|
Provision for Income Tax
|
-- | -- | -- | -- | 0 |
|
Net Income from Continuing Operations
|
-72,236 | -133,465 | -29,447 | -64,666 | 12,551 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-72,236 | -133,465 | -29,447 | -64,666 | 12,551 |
|
Net Income after Non-Controlling/Minority Interests
|
-72,236 | -133,465 | -29,447 | -64,666 | 12,551 |
|
Net Income Available to Common Stockholders
|
-72,236 | -133,465 | -29,447 | -64,666 | 12,551 |
|
Dilution to Earnings
|
-10,561 | 0 | 0 | -6,683 | -27,686 |
|
Diluted Net Income Available to Common Stockholders
|
-82,797 | -133,465 | -29,447 | -71,349 | -15,135 |
| Basic EPS
|
-2.61 | -4.16 | -2.07 | -5.96 | 1.52 |
| Diluted EPS
|
-2.77 | -4.16 | -2.07 | -5.96 | -1.48 |
|
Basic Weighted Average Shares Outstanding
|
98,011.6280 | 32,104.5820 | 14,256.2630 | 10,857.7370 | 8,161.7270 |
|
Diluted Weighted Average Shares Outstanding
|
118,275.8010 | 32,104.5820 | 14,256.2630 | 10,857.7370 | 10,190.8470 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-66,747 | -122,734 | -22,173 | -56,519 | 12,223 |
|
EBITDA
|
-66,598 | -122,638 | -22,108 | -56,463 | 12,271 |
|
Normalized EBITDA
|
-24,942 | -26,033 | -16,285 | 36,711 | 12,512 |
|
Normalized Income
|
-30,580 | -36,860 | -23,624 | 28,508 | 12,728.8339 |
|
Total Unusual Items
|
41,656 | 96,605 | 5,823 | 93,174 | 241 |
12/31/2022 - 3/1/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade